95 related articles for article (PubMed ID: 7992085)
1. The role of somatostatin analogs in the control of tumor growth.
Lamberts SW; Reubi JC; Krenning EP
Semin Oncol; 1994 Oct; 21(5 Suppl 13):61-4. PubMed ID: 7992085
[No Abstract] [Full Text] [Related]
2. Rationale for treating cancer with somatostatin analogs.
Minuto F; Ferone D; Arvigo M; Barreca A
J Endocrinol Invest; 2003; 26(8 Suppl):117-9. PubMed ID: 15233226
[No Abstract] [Full Text] [Related]
3. The effects of somatostatin analogs on biochemical parameters in acromegaly.
Liuzzi A; Marzullo P
J Endocrinol Invest; 2003; 26(8 Suppl):46-9. PubMed ID: 15233212
[No Abstract] [Full Text] [Related]
4. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptors and breast cancer.
Cameron Smith M; Orlando C; Serio M; Maggi M
J Endocrinol Invest; 2003; 26(8 Suppl):125-30. PubMed ID: 15233228
[No Abstract] [Full Text] [Related]
6. Role of somatostatin analogs in the management of rare tumors and diseases.
Palmieri G; Montella L
J Endocrinol Invest; 2003; 26(8 Suppl):89-91. PubMed ID: 15233221
[No Abstract] [Full Text] [Related]
7. Role of somatostatin analogs in the clinical management of non-neuroendocrine solid tumors.
Kvols LK; Woltering EA
Anticancer Drugs; 2006 Jul; 17(6):601-8. PubMed ID: 16917205
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of somatostatin.
Pyronnet S; Bousquet C; Najib S; Azar R; Laklai H; Susini C
Mol Cell Endocrinol; 2008 May; 286(1-2):230-7. PubMed ID: 18359151
[TBL] [Abstract][Full Text] [Related]
9. Re: Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer.
Buscail L
J Natl Cancer Inst; 1998 Jun; 90(11):864-5. PubMed ID: 9625179
[No Abstract] [Full Text] [Related]
10. New insights on SOM230, a universal somatostatin receptor ligand.
Boerlin V; van der Hoek J; Beglinger Ch; Poon KW; Hartmann S; Dutreix C; Kovarik JM; Bruns Ch; Weckbecker G; Lewis I; Schnieper P; Hofland LJ; Lamberts SW
J Endocrinol Invest; 2003; 26(8 Suppl):14-6. PubMed ID: 15233205
[No Abstract] [Full Text] [Related]
11. Perspectives of new potential therapeutic applications of somatostatin analogs.
Pawlikowski M; Melen-Mucha G
Neuro Endocrinol Lett; 2003; 24(1-2):21-7. PubMed ID: 12743527
[TBL] [Abstract][Full Text] [Related]
12. Responsiveness to somatostatin analog treatment and potentials of novel somatostatin analog.
Hofland LJ
J Endocrinol Invest; 2003; 26(8 Suppl):8-13. PubMed ID: 15233204
[No Abstract] [Full Text] [Related]
13. The role of somatostatin analogs in the management of prostate cancer.
Sinisi AA; Rossi V; Prezioso D; Notaro A; Bellastella G; Panza N; Bellastella A; Pasquali D
J Endocrinol Invest; 2003; 26(8 Suppl):120-4. PubMed ID: 15233227
[No Abstract] [Full Text] [Related]
14. Biology of somatostatin in breast cancer.
Watt HL; Kharmate G; Kumar U
Mol Cell Endocrinol; 2008 May; 286(1-2):251-61. PubMed ID: 18308465
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
Janson ET; Oberg K
Cancer Chemother Biol Response Modif; 2003; 21():535-46. PubMed ID: 15338762
[No Abstract] [Full Text] [Related]
16. Somatostatin analogs in the treatment of neuroendocrine gastroenteropancreatic and intrathoracic tumors.
Janson ET
J Endocrinol Invest; 2005; 28(11 Suppl International):137-40. PubMed ID: 16625863
[TBL] [Abstract][Full Text] [Related]
17. The role of somatostatin and somatostatin analogs in the pathophysiology of the human immune system.
Dalm VA; Hofland LJ; Ferone D; Croxen R; Lamberts SW; van Hagen PM
J Endocrinol Invest; 2003; 26(8 Suppl):94-102. PubMed ID: 15233222
[No Abstract] [Full Text] [Related]
18. The role of somatostatin analogs in the management of immunoproliferative disease.
Ferone D; Arvigo M; Semino C; Pivonello R; van Hagen PM; Barreca A; Minuto F
J Endocrinol Invest; 2003; 26(8 Suppl):103-8. PubMed ID: 15233223
[No Abstract] [Full Text] [Related]
19. Somatostatin analogs as radiodiagnostic tools.
de Herder WW; Lamberts SW
Rev Endocr Metab Disord; 2005 Jan; 6(1):23-7. PubMed ID: 15711911
[No Abstract] [Full Text] [Related]
20. The role of somatostatin and its analogs in the diagnosis and treatment of tumors.
Lamberts SW; Krenning EP; Reubi JC
Endocr Rev; 1991 Nov; 12(4):450-82. PubMed ID: 1684746
[No Abstract] [Full Text] [Related]
[Next] [New Search]
